Contents

Current Pharmaceutical Design, Volume 15 - Number 20

Editorial [Hot Topic: ADAMs: Targets for Drug Discovery (Executive Editor: Marcia L. Moss)]

, 15(20): 2270 - 2271

Marcia L. Moss


DOI: 10.2174/138161209788682406




ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies

, 15(20): 2272 - 2281

Garrit Koller, Uwe Schlomann, Panagiota Golfi, Taheera Ferdous, Silvia Naus and Jorg W. Bartsch


DOI: 10.2174/138161209788682361




ADAM9 as a Potential Target Molecule in Cancer

, 15(20): 2282 - 2287

Lucie Peduto


DOI: 10.2174/138161209788682415




ADAM10 as a Therapeutic Target for Cancer and Inflammation

, 15(20): 2288 - 2299

Howard C. Crawford, Peter J. Dempsey, Gordon Brown, Liana Adam and Marcia L. Moss


DOI: 10.2174/138161209788682442




Targeting ADAM12 in Human Disease: Head, Body or Tail?

, 15(20): 2300 - 2310

J. Jacobsen and U. M. Wewer


DOI: 10.2174/138161209788682389




The Therapeutic Potential of ADAM15

, 15(20): 2311 - 2318

Neali Lucas, Abdo J. Najy and Mark L. Day


DOI: 10.2174/138161209788682370




ADAM17 as a Therapeutic Target in Multiple Diseases

, 15(20): 2319 - 2335

Joaquin Arribas and Cary Esselens


DOI: 10.2174/138161209788682398




ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases

, 15(20): 2336 - 2348

Bin Qi, Robert G. Newcomer and Qing-Xiang Amy Sang


DOI: 10.2174/138161209788682352




ADAM28 as a Target for Human Cancers

, 15(20): 2349 - 2358

Satsuki Mochizuki and Yasunori Okada


DOI: 10.2174/138161209788682424




A Review of the ADAMTS Family, Pharmaceutical Targets of the Future

, 15(20): 2359 - 2374

Micky D. Tortorella, Fransiska Malfait, Ruteja A Barve, Huey-Sheng Shieh and Anne-Marie Malfait


DOI: 10.2174/138161209788682433




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science